¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Vaccine, inactivated polio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® vaccine ÇÑ±Û ¹é½Å
¼³¸í   
  Àü¿°º´¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ÁÖ±â À§ÇØ »ýü¿¡ Åõ¿©Çϴ Ç׿øÀÇ Çϳª. º´¿øÃ¼ ¹× µ¶¼Ò¿¡ ´ëÇÑ ¹æ¾î±â±¸¸¦ °­È­ÇÒ ¸ñÀûÀ¸·Î »ç¿ëµÇ´Â ¹Ì»ý¹°Á¦Á¦¸¦ ¸»ÇÑ´Ù. ÇÁ¶û½ºÀÇ ¹Ì»ý¹°ÇÐÀÚ L. ÆÄ½ºÅ𸣿¡ ÀÇÇÏ¿© Á¦Ã¢µÈ ¿ë¾î·Î¼­, ¾î¶² °¨¿°Áõ¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ¾ò±â À§ÇÏ¿© ±× º´¿ø ¹Ì»ý¹° ¶Ç´Â ±× µ¶¼Ò¾×¿¡ Àû´çÇÑ Á¶ÀÛÀ» °¡ÇÏ¿© ¸¸µç °ÍÀ» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • polio
    ȸ»öÁúô¼ö¿°
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û
  • attenuated vaccine
    ¾à(µ¶)È­¹é½Å, ¾àµ¶¹é½Å
  • hepatitis B vaccine
    BÇü°£¿°¹é½Å
  • human diploid cell vaccine
    »ç¶÷µÎ¹è¼ö¼¼Æ÷¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å, »ç¹é½Å
  • live vaccine
    »ý¹é½Å
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • rabies vaccine
    ±¤°ßº´¹é½Å
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • vaccine
    ¹é½Å
  • vaccine rash
    ¹é½Å¹ßÁø
  • vaccine therapy
    ¹é½Å¿ä¹ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • vaccine
    ¹é½Å
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å, ¾àµ¶¹é½Å
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • killed vaccine
    »ç¸ê¹é½Å, »ç¹é½Å
  • live vaccine
    »ý¹é½Å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • polio
    (¢¡poliomyelitis) ȸ»öÁúô¼ö¿°
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å, ¾àµ¶¹é½Å
  • corresponding vaccine
    µ¿Á¾±Õ¹é½Å
  • vaccine exanthem
    Á¾µÎ¹ßÁø
  • internal image vaccine
    ³»ºÎ¿µ»ó¹é½Å, °³º°Æ¯ÀÌÇü¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å
  • live vaccine
    »ý¹é½Å
  • live vaccine virus
    »ý¹é½Å¹ÙÀÌ·¯½º
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • vaccine rash
    ¹é½Å¹ßÁø
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • vaccine therapy
    ¹é½Å¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • infantile paralysis =polio
    ¼Ò¾Æ¸¶ºñ(á³ä®Ø«Ýö), ¿µ¾Æ¼º ¸¶ºñ.
  • poliomyelitis =polio
    ¼Ò¾Æ¸¶ºñ, Æú¸®¿À, ȸ»öô¼ö¿°.
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û.
  • BCG vaccine
    ºñ½ÃÁö¹é½Å
  • Bacillus Calmette Gue rin vaccine =BCG v.
    BCG ¹é½Å.
  • Coxs vaccine
    ÄÛ½º¿ÎÁø<¹é½Å>
  • DP vaccine
    µðÇǹé½Å
  • DPT vaccine
    µðÇÇÆ¼¹é½Å
  • DTP vaccine
    µðƼÇǹé½Å
  • Sabin vaccine
    ¼¼À̺ó¹é½Å
  • Sabins vaccine
    ¼¼À̺ó¹é½Å.
  • Sabins vaccine
    ¼¼À̺ó Æú¸®¿À¹é½Å
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • inactivated vaccine
    ºñȰ¼ºÈ­¹é½Å.
  • vaccine, inactivated virus
    ºÒȰ¼ºÈ­ ¹ÙÀÌ·¯½º ¹é½Å
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û.
  • bulbar polio
    ¿¬¼ö¼º Æú¸®¿À.
  • infantile paralysis =polio
    ¼Ò¾Æ¸¶ºñ(á³ä®Ø«Ýö), ¿µ¾Æ¼º ¸¶ºñ.
  • mouse polio
    ¸¶¿ì½ºÆú¸®¿À.
  • nonparalytic polio
    ºñ¸¶ºñ¼º Æú¸®¿À, ºñ¸¶ºñ¼º ȸ¹é¼ö¿°.
  • paralytic polio
    ¸¶ºñ¼º Æú¸®¿À.
  • poliomyelitis =polio
    ¼Ò¾Æ¸¶ºñ, Æú¸®¿À, ȸ»öô¼ö¿°.
  • spinal paralytic polio
    ô¼öÇü ¸¶ºñ¼º Æú¸®¿À(ô±âÐû¡Ø«Ýöàõ¡­ )
  • anthrax vaccine
    źÀú¹é½Å.
  • antismallpox vaccine
    ¸¶¸¶¹é½Å.
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inactivated vaccine
    ºÒȰ¼ºÈ­(ÝÕüÀàõûù) ¹é½Å
  • autogenous vaccine
    ÀÚ°¡(í»Ê«)¹é½Å
  • live vaccine
    »ý(ßæ)¹é½Å
  • mixed vaccine
    È¥¼º(ûèà÷)¹é½Å
  • multivalent vaccine
    ´Ù°¡(Òýʤ) ¹é½Å
  • polyvalent vaccine
    ´Ù°¡(Òýʤ) ¹é½Å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vaccine
    ¹é½Å, ¿ÎÁø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
eIPV enhanced inactivated polio vaccine
OPV Oral Polio-Vaccine; °æ±¸¿ë ¼Ò¾Æ¸¶ºñ ¹é½Å
TOPV Trivalent Oral Polio(myelitis) Vaccine; °æ±¸¿ë ¼Ò¾Æ¸¶ºñ È¥ÇÕ¹é½Å
OPV oral polio vaccine
PV pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IPV Inactivated Polio-Vaccine
IPV Inactivated poliovirus vaccine
OPV Oral Polio Vaccine
PPS Post-polio syndrome
BPV Bordatella pertussis vaccine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • polio vaccine
    ¼Ò¾Æ ¸¶ºñ ¹é½Å
    ¼Ò¾Æ ¸¶ºñÀÇ ¿¹¹æÀ» À§ÇÏ¿© ¾²ÀÌ´Â ¸é¿ª¿ø.
  • paralytic polio
    ¸¶ºñ¼º Æú¸®¿À
  • anticaries vaccine
    Ç׿ì½Ä ¿ÎÁø
  • antiplaque vaccine
    Ç×ġŠ¿ÎÁø
  • cholera vaccine
    ÄÝ·¹¶ó ¹é½Å
    ºÒȰ¼ºÈ­ cholerarbsÀ» »ç¿ëÇÑ cholera¿ë ¹é½Å. Á¢Á¾À» ÇØµµ °¨¿° ¿¹¹æ·ÂÀº ºÒÃæºÐÇÏ¿© ¿ÏÀüÇÑ È¿°ú´Â ±â´ëÇÒ ¼ö ¾ø´Ù.
  • corresponding vaccine
    µ¿Á¾ ±Õ ¹é½Å
  • herpes type I vaccine
    Á¦1Çü Æ÷Áø ¹é½Å
  • influenza vaccine
    ÀÎÇ÷翣ÀÚ ¹é½Å
    ÀÎÇ÷翣ÀÚÀÇ ¿¹¹æ¿¡ ¾²ÀÌ´Â ¹é½Å. ´Þ°¿ ¹è¾ç¿¡ ÀÇÇØ Áõ½Ä½ÃŲ ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º¿¡¼­ ´Þ°¿ ¼ººÐÀ» Á¦°ÅÇϰí, Æ÷¸£¸»¸°À» °¡ÇØ °¨¿°·ÂÀ» ¾ø¾Ø °ÍÀÌ´Ù. À¯ÇàÇÏ´Â ¹ÙÀÌ·¯½ºÀÇ Çü°ú ¹é½ÅÀÇ ¹ÙÀÌ·¯½ºÀÇ ÇüÀÌ ¸ÂÁö ¾ÊÀ¸¸é È¿°ú°¡ ÀûÀ¸¹Ç·Î, Ç×»ó ÃÖ±Ù¿¡ À¯ÇàÇÑ 2¡­3°³ À¯ÇüÀÇ »õ·Î¿î ¹ÙÀÌ·¯½º·Î Á¦Á¶µÈ´Ù. Á¦Ç°Àº ¹«»ö Åõ¸íÇÑ ¾×À¸·Î, ¹ÐºÀÇÏ¿© 2¡­5 ¡É¿¡¼­ º¸Á¸µÈ´Ù. À¯È¿ ±â°£Àº °ËÁ¤ ÇÕ°ÝÇÑ ³¯·ÎºÎÅÍ 1³â 6°³¿ùÀ̸ç, 1ȸÀÇ ¾çÀº 15¼¼ ÀÌ»óÀº 0.5 cc, 6¡­15¼¼ ¹Ì¸¸Àº 0.3 cc, 1¡­6¼¼ ¹Ì¸¸Àº 0.2 cc, 1¼¼ ¹Ì¸¸Àº 0.1 ccÀÌ´Ù. ºÎÀÛ¿ëÀº Áֻ縦 ¸ÂÀº ÀÚ¸®°¡ ¾à°£ º×°í ¾ÆÇÁ°Å³ª, ÀϽÃÀûÀÎ ¹ß¿­À̳ª °¡º­¿î °¨±â Áõ¼¼°¡ ³ªÅ¸³¯ ¼ö Àִµ¥, ¿°·ÁÇÒ °ÍÀº ¸ø µÈ´Ù. ´Ù¸¸, ´Þ°¿ ¾Ë·¹¸£±âÀÎ »ç¶÷Àº Áֻ縦 ÇÇÇϰí, Áöº´ÀÌ ÀÖ´Â »ç¶÷Àº ÀÇ»ç¿Í »ó´ãÇÑ´Ù. ¿¹¹æ Á¢Á¾ÀÇ È¿°ú´Â ÁÖ»ç ÈÄ 2ÁÖ°£ÀÌ Áö³ª¾ß ³ªÅ¸³ª¸ç, 3¡­6°³¿ù °£ Áö¼ÓÇϹǷÎ, ¸Å³â À¯Çà±â¿¡ ¾Õ¼­ 10¡­11¿ù¿¡ Áֻ縦 ¸Â´Â °ÍÀÌ ÁÁ´Ù.
  • killed vaccine
    »ç¹é½Å
  • live vaccine
    »ý ¹é½Å
  • mixed vaccine
    È¥ÇÕ ¹é½Å
    µÎ Á¾·ù ÀÌ»óÀÇ ¿¹¹æÁ¢Á¾ Àç·á¸¦ È¥ÇÕÇÑ ¹é½Å. È¥ÇÕÇÔÀ¸·Î½á °¢ ¼ººÐÀÇ ¸é¿ª¿ø¼º¿¡ °¨¼ÕÀÌ ¾ø´Â °æ¿ì ÇàÇÏ¿©Áø´Ù. °¡Àå º¸ÆíÀûÀ¸·Î ¾²À̰í ÀÖ´Â °Í¿¡´Â ÀåÆ¼Çª½º¿Í ÆÄ¶óƼǪ½ºÀÇ È¥ÇÕ ¹é½Å, ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½ºÀÇ AÇü°ú BÇüÀÇ È¥ÇÕ ¹é½Å µîÀÌ ÀÖ´Ù. ÀåÆ¼Çª½º, ÆÄ¶óƼǪ½º È¥ÇÕ ¹é½ÅÀº ÀåÆ¼Çª½º±Õ°ú A±Õ ¹× ÆÄ¶óƼǪ½º B±ÕÀ» »ì±ÕÇÏ¿© ÀÏÁ¤ÇÑ ºñÀ²·Î È¥ÇÕÇÑ °ÍÀ¸·Î¼­, ÇÇÇÏ ÁÖ»ç ¶Ç´Â Çdz» ÁÖ»çÇÑ´Ù.
  • Nicolle-Blaizot's vaccine
    ´ÏÄÝ, ºí·¹ÀÌÁ¶ ¿ÎÁø
    ÀÓ±ÕÀ¸·Î ¸¸µç ÀÓÁú ¿ÎÁø.
  • oral poliovirus vaccine
    ¼Ò¾Æ¸¶ºñ °æ±¸ ¹é½Å, Æú¸®¿À °æ±¸ ¹é½Å
  • rabies vaccine
    ±¤°ßº´ ¹é½Å
    ±¤°ßº´ÀÇ ¹ßº´°ú ¿¹¹æÀ» ¸ñÀûÀ¸·Î °³¹ßµÈ ¹é½Å. 1884³â ÇÁ¶û½ºÀÇ L. ÆÄ½ºÅ𸣰¡ ¼§º£¸¦¶û
  • rubella vaccine
    dzÁø ¹é½Å
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
inactivated polio vaccine <pharmacology, virology> An inactivated vaccination, administered by injection to children for protection against the polio virus. Typically given at 2, 4 and 15 months. A final vaccine is recommended at 4-6 years.
(27 Sep 1997)
inactivated poliovirus vaccine Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine.
See: Salk vaccine.
(05 Mar 2000)
oral polio vaccine <drug> A live vaccination, administered orally to children for protection against the polio virus. Typically given at 2, 4 and 15 months. A final oral vaccine is recommended at 4-6 years.
(27 Sep 1997)
vaccines, inactivated Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
(12 Dec 1998)
inactivated serum <immunology> Serum that has been heated 50°C for 30 minutes to destroy the lytic activity of complement.
(05 Mar 2000)
vaccination, polio The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(12 Dec 1998)
polio <virology> An epidemic viral infection which attacks the motor neurons of the anterior horns in the brainstem and spinal cord.
Vaccination against this disease is recommended.
(27 Sep 1997)
polio immunization <virology> The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine).
Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth.
Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age.
Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(21 Jun 1999)
polio vaccination <virology> The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine).
Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth.
Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age.
Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(21 Jun 1999)
immunization, polio The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(12 Dec 1998)
French polio Colloquialism for Guillain-Barre syndrome.
(05 Mar 2000)
acellular vaccine <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells.
(13 Nov 1997)
adjuvant vaccine A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate).
(05 Mar 2000)
aqueous vaccine A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion.
(05 Mar 2000)
attenuated vaccine Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polio
    ¼Ò¾Æ¸¶ºñÁõ
  • polio
    ¼Ò¾Æ¸¶ºñ
  • vaccine
    ¿ìµÎÁ¾
  • Sabin vaccine
    ¼¼À̺ó ¹é½Å(¼Ò¾Æ¸¶ºñ »ý ¹é½Å)
  • Salk vaccine
    ¼ÒÅ©¹é½Å(¼Ò¾Æ¸¶ºñ ¿¹¹æ¿ë)
  • vaccine
    ¿ìµÎÁ¾;¹é½Å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á